THANK YOU FOR SUBSCRIBING
Alan Costello, Venture Investment Leader, NDRC
R. Mark Adams, CIO, Good Start Genetics, Cambridge, MA
Dan Hausman, CTO, ConvergeHEALTH by Deloitte
Thomas Laurita, President, and CEO,NewLeaf Symbiotics
Owe Orwar, CEO,Oblique Therapeutics
Prof. Dr. Heinz-Herbert Fiebig, CEO and Dr. Vincent Vuaroqueaux, CTO,4HF Biotec
David Perry, President, CEO & Director, Indigo
Arne Fleisher, Chief Operations & Engineering Branch (OEB), OCICB, NIAID/NIH
Jeff Lin, VC Investor, Senior Principal at VC at iGlobe Partners